rolofylline has been researched along with Renal Insufficiency in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (25.00) | 29.6817 |
| 2010's | 6 (75.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bloomfield, DM; Cleland, JG; Cotter, G; Damman, K; Davison, B; Dittrich, HC; Fiuzat, M; Givertz, MM; Hillege, HL; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Teerlink, JR; Valente, MA; Van Veldhuisen, DJ; Voors, AA | 1 |
| Berezikov, E; Bloomfield, DM; Bruno, N; Cleland, JG; Cotter, G; Davison, B; de Boer, RA; Dittrich, HC; Givertz, MM; Hillege, HL; Metra, M; O'Connor, CM; Ovchinnikova, ES; Pinto, YM; Ponikowski, P; Schmitter, D; Teerlink, JR; ter Maaten, JM; Valente, MA; van der Harst, P; van der Meer, P; van Veldhuisen, DJ; Vegter, EL; Voors, AA | 1 |
| Bloomfield, DM; Cleland, JG; Cotter, G; Davison, BA; Dittrich, HC; Edwards, C; Givertz, MM; Massie, BM; Metra, M; Milo, O; O'Connor, CM; Ponikowski, P; Senger, S; Teerlink, JR; Voors, AA | 1 |
| Bloomfield, DM; Cotter, G; Dittrich, HC; Massie, BM; Metra, M; O'Connor, CM; Weatherley, BD | 1 |
| Bloomfield, DM; Cotter, G; Dittrich, HC; Massie, BM; Metra, M; O'Connor, CM; Ponikowski, P; Weatherley, BD | 1 |
| Chen, E; Cotter, G; Dittrich, H; Fujita, KP; Givertz, MM; Massie, BM; Metra, M; Mitrovic, V; Murray, M; O'Connor, CM; Ponikowski, P; Weatherley, BD | 1 |
| Carson, PE; Cleland, JG; Cotter, G; Davison, BA; Delucca, P; Dittrich, H; Givertz, MM; Hauptman, PJ; Iragui, VJ; Lovett, DH; Mansoor, GA; Massie, BM; Metra, M; Miller, AB; Mohr, JP; O'Connor, CM; Piña, IL; Ponikowski, P; Salerno, CM; Teerlink, JR; Thomson, S; Varosy, PD; Voors, AA; Wolko, D; Zile, MR | 1 |
| Dittrich, HC; Fields, TK; Givertz, MM; Massie, BM; Pearson, LL | 1 |
6 trial(s) available for rolofylline and Renal Insufficiency
| Article | Year |
|---|---|
Diuretic response in acute heart failure: clinical characteristics and prognostic significance.
Topics: Acute Disease; Aged; Analysis of Variance; Atherosclerosis; Bumetanide; Diabetes Complications; Diuretics; Dose-Response Relationship, Drug; Drug Resistance; Dyspnea; Female; Furosemide; Heart Failure; Humans; Hypotension; Male; Patient Readmission; Renal Insufficiency; Sulfonamides; Torsemide; Treatment Outcome; Weight Loss; Xanthines | 2014 |
MicroRNAs relate to early worsening of renal function in patients with acute heart failure.
Topics: Acute Disease; Aged; Biomarkers; Creatinine; Disease Progression; Diuretics; Double-Blind Method; Early Diagnosis; Enzyme-Linked Immunosorbent Assay; Female; Follow-Up Studies; Gene Expression Regulation; Glomerular Filtration Rate; Heart Failure; Humans; Male; MicroRNAs; Real-Time Polymerase Chain Reaction; Renal Insufficiency; Retrospective Studies; Xanthines | 2016 |
The PROTECT pilot study: a randomized, placebo-controlled, dose-finding study of the adenosine A1 receptor antagonist rolofylline in patients with acute heart failure and renal impairment.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Cardiovascular Agents; Confidence Intervals; Disease Progression; Diuresis; Dyspnea; Female; Heart Failure; Humans; Male; Pilot Projects; Renal Insufficiency; Risk; Risk Factors; Xanthines | 2008 |
Haemodynamic effects of rolofylline in the treatment of patients with heart failure and impaired renal function.
Topics: Aged; Diuretics; Double-Blind Method; Female; Heart Failure; Hemodynamics; Humans; Kidney Function Tests; Least-Squares Analysis; Male; Middle Aged; Prospective Studies; Renal Insufficiency; Sodium Potassium Chloride Symporter Inhibitors; Xanthines | 2010 |
The safety of an adenosine A(1)-receptor antagonist, rolofylline, in patients with acute heart failure and renal impairment: findings from PROTECT.
Topics: Acute Disease; Adenosine A1 Receptor Antagonists; Aged; Aged, 80 and over; Female; Follow-Up Studies; Heart Failure; Hospitalization; Humans; Male; Middle Aged; Renal Insufficiency; Risk Factors; Stroke; Time Factors; Xanthines | 2012 |
The effects of KW-3902, an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.
Topics: Aged; Creatinine; Diuresis; Diuretics; Dose-Response Relationship, Drug; Double-Blind Method; Drug Resistance; Female; Furosemide; Heart Failure; Humans; Infusions, Intravenous; Male; Middle Aged; Renal Insufficiency; Sodium; Treatment Outcome; Xanthines | 2007 |
2 other study(ies) available for rolofylline and Renal Insufficiency
| Article | Year |
|---|---|
Patient journey after admission for acute heart failure: length of stay, 30-day readmission and 90-day mortality.
Topics: Acute Disease; Aged; Comorbidity; Diabetes Mellitus; Disease Progression; Diuretics; Edema; Female; Heart Failure; Hospitalization; Humans; Length of Stay; Logistic Models; Male; Middle Aged; Mortality; Multivariate Analysis; Myocardial Ischemia; Odds Ratio; Patient Readmission; Proportional Hazards Models; Randomized Controlled Trials as Topic; Renal Insufficiency; Severity of Illness Index; Xanthines | 2016 |
Physician-determined worsening heart failure: a novel definition for early worsening heart failure in patients hospitalized for acute heart failure--association with signs and symptoms, hospitalization duration, and 60-day outcomes.
Topics: Aged; Aged, 80 and over; Female; Heart Failure; Humans; Length of Stay; Male; Middle Aged; Patient Readmission; Prognosis; Renal Insufficiency; Severity of Illness Index; Sodium Potassium Chloride Symporter Inhibitors; Xanthines | 2010 |